Figure 1. Specificity of the anti-advanced
lipoxidation end product antibodies. Representative dot blots showing
the specificity of the anti-advanced lipoxidation end product (ALE)
monoclonal antibodies to aldehyde-modified proteins.
anti-malondialdehyde (MDA)-lysine, anti-4-hydroxy-2-nonenal
(HNE)–histidine, and anti-4-hydroxyhexenal (HHE)-histidine monoclonal
antibodies reacted specifically with FDP-lysine human serum albumin
(HSA), MDA BSA (BSA), 4-HNE-HSA, and 4-HHE-HSA, respectively.